HIV cure trial mergers: Spotlighting the epigenetics of latency reversal

Bibliographic Details
Main Author: Paul W. Denton
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396422001967
_version_ 1828280664574656512
author Paul W. Denton
author_facet Paul W. Denton
author_sort Paul W. Denton
collection DOAJ
first_indexed 2024-04-13T08:02:27Z
format Article
id doaj.art-786eaa5543a844239625aed03c8117b5
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-04-13T08:02:27Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-786eaa5543a844239625aed03c8117b52022-12-22T02:55:15ZengElsevierEBioMedicine2352-39642022-05-0179104012HIV cure trial mergers: Spotlighting the epigenetics of latency reversalPaul W. Denton0Department of Biology, University of Nebraska Omaha, Omaha, NE, USAhttp://www.sciencedirect.com/science/article/pii/S2352396422001967
spellingShingle Paul W. Denton
HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
EBioMedicine
title HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
title_full HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
title_fullStr HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
title_full_unstemmed HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
title_short HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
title_sort hiv cure trial mergers spotlighting the epigenetics of latency reversal
url http://www.sciencedirect.com/science/article/pii/S2352396422001967
work_keys_str_mv AT paulwdenton hivcuretrialmergersspotlightingtheepigeneticsoflatencyreversal